nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—type 2 diabetes mellitus	0.251	0.614	CbGaD
Ethosuximide—CYP3A4—type 2 diabetes mellitus	0.158	0.386	CbGaD
Ethosuximide—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0491	0.14	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0491	0.14	CbGbCtD
Ethosuximide—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0368	0.105	CbGbCtD
Ethosuximide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0294	0.0838	CbGbCtD
Ethosuximide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0262	0.0747	CbGbCtD
Ethosuximide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.024	0.0683	CbGbCtD
Ethosuximide—CYP3A5—Losartan—type 2 diabetes mellitus	0.0228	0.0649	CbGbCtD
Ethosuximide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.021	0.0597	CbGbCtD
Ethosuximide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.019	0.054	CbGbCtD
Ethosuximide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0144	0.0409	CbGbCtD
Ethosuximide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0138	0.0393	CbGbCtD
Ethosuximide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0138	0.0393	CbGbCtD
Ethosuximide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.013	0.0371	CbGbCtD
Ethosuximide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0097	0.0277	CbGbCtD
Ethosuximide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00887	0.0253	CbGbCtD
Ethosuximide—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000258	0.00144	CcSEcCtD
Ethosuximide—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000256	0.00144	CcSEcCtD
Ethosuximide—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000255	0.00143	CcSEcCtD
Ethosuximide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000255	0.00143	CcSEcCtD
Ethosuximide—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000254	0.00142	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000253	0.00142	CcSEcCtD
Ethosuximide—Rash—Repaglinide—type 2 diabetes mellitus	0.000252	0.00142	CcSEcCtD
Ethosuximide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000252	0.00141	CcSEcCtD
Ethosuximide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000252	0.00141	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00141	CcSEcCtD
Ethosuximide—Eye disorder—Metformin—type 2 diabetes mellitus	0.000252	0.00141	CcSEcCtD
Ethosuximide—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000251	0.00141	CcSEcCtD
Ethosuximide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000251	0.00141	CcSEcCtD
Ethosuximide—Headache—Repaglinide—type 2 diabetes mellitus	0.000251	0.00141	CcSEcCtD
Ethosuximide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00025	0.0014	CcSEcCtD
Ethosuximide—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00025	0.0014	CcSEcCtD
Ethosuximide—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.00025	0.0014	CcSEcCtD
Ethosuximide—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000249	0.0014	CcSEcCtD
Ethosuximide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000249	0.0014	CcSEcCtD
Ethosuximide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000248	0.00139	CcSEcCtD
Ethosuximide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000248	0.00139	CcSEcCtD
Ethosuximide—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000246	0.00138	CcSEcCtD
Ethosuximide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000246	0.00138	CcSEcCtD
Ethosuximide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000245	0.00137	CcSEcCtD
Ethosuximide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000245	0.00137	CcSEcCtD
Ethosuximide—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000244	0.00137	CcSEcCtD
Ethosuximide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000244	0.00137	CcSEcCtD
Ethosuximide—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00137	CcSEcCtD
Ethosuximide—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000244	0.00137	CcSEcCtD
Ethosuximide—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000244	0.00136	CcSEcCtD
Ethosuximide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000243	0.00136	CcSEcCtD
Ethosuximide—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000243	0.00136	CcSEcCtD
Ethosuximide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00136	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000241	0.00135	CcSEcCtD
Ethosuximide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00135	CcSEcCtD
Ethosuximide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000239	0.00134	CcSEcCtD
Ethosuximide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00134	CcSEcCtD
Ethosuximide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000238	0.00133	CcSEcCtD
Ethosuximide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000238	0.00133	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000237	0.00133	CcSEcCtD
Ethosuximide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000237	0.00133	CcSEcCtD
Ethosuximide—Malnutrition—Metformin—type 2 diabetes mellitus	0.000235	0.00132	CcSEcCtD
Ethosuximide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000234	0.00131	CcSEcCtD
Ethosuximide—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00023	0.00129	CcSEcCtD
Ethosuximide—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000229	0.00129	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00128	CcSEcCtD
Ethosuximide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000228	0.00128	CcSEcCtD
Ethosuximide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000228	0.00128	CcSEcCtD
Ethosuximide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00127	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000227	0.00127	CcSEcCtD
Ethosuximide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000227	0.00127	CcSEcCtD
Ethosuximide—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000226	0.00127	CcSEcCtD
Ethosuximide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000226	0.00126	CcSEcCtD
Ethosuximide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00126	CcSEcCtD
Ethosuximide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000225	0.00126	CcSEcCtD
Ethosuximide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000222	0.00125	CcSEcCtD
Ethosuximide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000222	0.00124	CcSEcCtD
Ethosuximide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000222	0.00124	CcSEcCtD
Ethosuximide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00124	CcSEcCtD
Ethosuximide—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000222	0.00124	CcSEcCtD
Ethosuximide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00124	CcSEcCtD
Ethosuximide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00022	0.00124	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00022	0.00123	CcSEcCtD
Ethosuximide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000219	0.00123	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000218	0.00122	CcSEcCtD
Ethosuximide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000217	0.00122	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000215	0.00121	CcSEcCtD
Ethosuximide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000213	0.0012	CcSEcCtD
Ethosuximide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000213	0.00119	CcSEcCtD
Ethosuximide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000212	0.00119	CcSEcCtD
Ethosuximide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00118	CcSEcCtD
Ethosuximide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000211	0.00118	CcSEcCtD
Ethosuximide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00118	CcSEcCtD
Ethosuximide—Rash—Glipizide—type 2 diabetes mellitus	0.000209	0.00117	CcSEcCtD
Ethosuximide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000209	0.00117	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000209	0.00117	CcSEcCtD
Ethosuximide—Headache—Glipizide—type 2 diabetes mellitus	0.000208	0.00116	CcSEcCtD
Ethosuximide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000206	0.00116	CcSEcCtD
Ethosuximide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000204	0.00115	CcSEcCtD
Ethosuximide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000204	0.00115	CcSEcCtD
Ethosuximide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000204	0.00114	CcSEcCtD
Ethosuximide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00114	CcSEcCtD
Ethosuximide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000204	0.00114	CcSEcCtD
Ethosuximide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000204	0.00114	CcSEcCtD
Ethosuximide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000203	0.00114	CcSEcCtD
Ethosuximide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000202	0.00113	CcSEcCtD
Ethosuximide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000202	0.00113	CcSEcCtD
Ethosuximide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000202	0.00113	CcSEcCtD
Ethosuximide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000201	0.00112	CcSEcCtD
Ethosuximide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.0002	0.00112	CcSEcCtD
Ethosuximide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00112	CcSEcCtD
Ethosuximide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00111	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000198	0.00111	CcSEcCtD
Ethosuximide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000198	0.00111	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000198	0.00111	CcSEcCtD
Ethosuximide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000197	0.00111	CcSEcCtD
Ethosuximide—Nausea—Glipizide—type 2 diabetes mellitus	0.000197	0.0011	CcSEcCtD
Ethosuximide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000197	0.0011	CcSEcCtD
Ethosuximide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000196	0.0011	CcSEcCtD
Ethosuximide—Rash—Glimepiride—type 2 diabetes mellitus	0.000195	0.00109	CcSEcCtD
Ethosuximide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000195	0.00109	CcSEcCtD
Ethosuximide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00109	CcSEcCtD
Ethosuximide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00109	CcSEcCtD
Ethosuximide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000194	0.00109	CcSEcCtD
Ethosuximide—Headache—Glimepiride—type 2 diabetes mellitus	0.000194	0.00109	CcSEcCtD
Ethosuximide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00108	CcSEcCtD
Ethosuximide—Agitation—Losartan—type 2 diabetes mellitus	0.000192	0.00107	CcSEcCtD
Ethosuximide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00107	CcSEcCtD
Ethosuximide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000188	0.00105	CcSEcCtD
Ethosuximide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000188	0.00105	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000187	0.00105	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000187	0.00105	CcSEcCtD
Ethosuximide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000187	0.00105	CcSEcCtD
Ethosuximide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000187	0.00105	CcSEcCtD
Ethosuximide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000186	0.00104	CcSEcCtD
Ethosuximide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000185	0.00104	CcSEcCtD
Ethosuximide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000185	0.00104	CcSEcCtD
Ethosuximide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00103	CcSEcCtD
Ethosuximide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000184	0.00103	CcSEcCtD
Ethosuximide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00103	CcSEcCtD
Ethosuximide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000183	0.00103	CcSEcCtD
Ethosuximide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000183	0.00102	CcSEcCtD
Ethosuximide—Anorexia—Metformin—type 2 diabetes mellitus	0.000183	0.00102	CcSEcCtD
Ethosuximide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000182	0.00102	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000182	0.00102	CcSEcCtD
Ethosuximide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000181	0.00102	CcSEcCtD
Ethosuximide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000181	0.00101	CcSEcCtD
Ethosuximide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000181	0.00101	CcSEcCtD
Ethosuximide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00018	0.00101	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000179	0.00101	CcSEcCtD
Ethosuximide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000179	0.001	CcSEcCtD
Ethosuximide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000179	0.001	CcSEcCtD
Ethosuximide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000177	0.000994	CcSEcCtD
Ethosuximide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000177	0.000994	CcSEcCtD
Ethosuximide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000986	CcSEcCtD
Ethosuximide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000985	CcSEcCtD
Ethosuximide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000176	0.000984	CcSEcCtD
Ethosuximide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000175	0.000979	CcSEcCtD
Ethosuximide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000174	0.000978	CcSEcCtD
Ethosuximide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000172	0.000966	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000172	0.000964	CcSEcCtD
Ethosuximide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000172	0.000963	CcSEcCtD
Ethosuximide—Somnolence—Metformin—type 2 diabetes mellitus	0.00017	0.000954	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00017	0.000953	CcSEcCtD
Ethosuximide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000169	0.000945	CcSEcCtD
Ethosuximide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000167	0.000937	CcSEcCtD
Ethosuximide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000167	0.000935	CcSEcCtD
Ethosuximide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000167	0.000933	CcSEcCtD
Ethosuximide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000166	0.000932	CcSEcCtD
Ethosuximide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000166	0.000929	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000165	0.000927	CcSEcCtD
Ethosuximide—Fatigue—Metformin—type 2 diabetes mellitus	0.000165	0.000926	CcSEcCtD
Ethosuximide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000165	0.000925	CcSEcCtD
Ethosuximide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000164	0.000921	CcSEcCtD
Ethosuximide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000164	0.000921	CcSEcCtD
Ethosuximide—Agitation—Ramipril—type 2 diabetes mellitus	0.000164	0.000921	CcSEcCtD
Ethosuximide—Anorexia—Losartan—type 2 diabetes mellitus	0.000162	0.000909	CcSEcCtD
Ethosuximide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000162	0.000909	CcSEcCtD
Ethosuximide—Rash—Glyburide—type 2 diabetes mellitus	0.000161	0.000901	CcSEcCtD
Ethosuximide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000161	0.000901	CcSEcCtD
Ethosuximide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000161	0.0009	CcSEcCtD
Ethosuximide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00016	0.000897	CcSEcCtD
Ethosuximide—Headache—Glyburide—type 2 diabetes mellitus	0.00016	0.000895	CcSEcCtD
Ethosuximide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000157	0.000881	CcSEcCtD
Ethosuximide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000157	0.000878	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000157	0.000878	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000156	0.000875	CcSEcCtD
Ethosuximide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000156	0.000873	CcSEcCtD
Ethosuximide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000155	0.000869	CcSEcCtD
Ethosuximide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000153	0.000858	CcSEcCtD
Ethosuximide—Urticaria—Metformin—type 2 diabetes mellitus	0.000152	0.000853	CcSEcCtD
Ethosuximide—Nausea—Glyburide—type 2 diabetes mellitus	0.000151	0.000849	CcSEcCtD
Ethosuximide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000151	0.000849	CcSEcCtD
Ethosuximide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000151	0.000849	CcSEcCtD
Ethosuximide—Somnolence—Losartan—type 2 diabetes mellitus	0.000151	0.000848	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000151	0.000847	CcSEcCtD
Ethosuximide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000151	0.000846	CcSEcCtD
Ethosuximide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000149	0.000836	CcSEcCtD
Ethosuximide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000148	0.000829	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000148	0.000828	CcSEcCtD
Ethosuximide—Fatigue—Losartan—type 2 diabetes mellitus	0.000147	0.000822	CcSEcCtD
Ethosuximide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000146	0.000816	CcSEcCtD
Ethosuximide—Rash—Gliclazide—type 2 diabetes mellitus	0.000144	0.000809	CcSEcCtD
Ethosuximide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000144	0.000808	CcSEcCtD
Ethosuximide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000144	0.000807	CcSEcCtD
Ethosuximide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000144	0.000805	CcSEcCtD
Ethosuximide—Headache—Gliclazide—type 2 diabetes mellitus	0.000143	0.000804	CcSEcCtD
Ethosuximide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000143	0.000802	CcSEcCtD
Ethosuximide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.000801	CcSEcCtD
Ethosuximide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000142	0.000797	CcSEcCtD
Ethosuximide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.000794	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000139	0.00078	CcSEcCtD
Ethosuximide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000139	0.00078	CcSEcCtD
Ethosuximide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000139	0.000779	CcSEcCtD
Ethosuximide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000137	0.00077	CcSEcCtD
Ethosuximide—Asthenia—Metformin—type 2 diabetes mellitus	0.000137	0.00077	CcSEcCtD
Ethosuximide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000762	CcSEcCtD
Ethosuximide—Urticaria—Losartan—type 2 diabetes mellitus	0.000135	0.000757	CcSEcCtD
Ethosuximide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000134	0.000754	CcSEcCtD
Ethosuximide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000134	0.00075	CcSEcCtD
Ethosuximide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000133	0.000746	CcSEcCtD
Ethosuximide—Rash—Valsartan—type 2 diabetes mellitus	0.000133	0.000743	CcSEcCtD
Ethosuximide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000133	0.000743	CcSEcCtD
Ethosuximide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000132	0.000741	CcSEcCtD
Ethosuximide—Headache—Valsartan—type 2 diabetes mellitus	0.000132	0.000739	CcSEcCtD
Ethosuximide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000131	0.000735	CcSEcCtD
Ethosuximide—Rash—Orlistat—type 2 diabetes mellitus	0.000131	0.000735	CcSEcCtD
Ethosuximide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000131	0.000734	CcSEcCtD
Ethosuximide—Headache—Orlistat—type 2 diabetes mellitus	0.00013	0.00073	CcSEcCtD
Ethosuximide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00013	0.000727	CcSEcCtD
Ethosuximide—Somnolence—Ramipril—type 2 diabetes mellitus	0.00013	0.000727	CcSEcCtD
Ethosuximide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000127	0.000711	CcSEcCtD
Ethosuximide—Dizziness—Metformin—type 2 diabetes mellitus	0.000127	0.00071	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000126	0.000706	CcSEcCtD
Ethosuximide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000126	0.000705	CcSEcCtD
Ethosuximide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000125	0.000702	CcSEcCtD
Ethosuximide—Nausea—Valsartan—type 2 diabetes mellitus	0.000125	0.0007	CcSEcCtD
Ethosuximide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000124	0.000693	CcSEcCtD
Ethosuximide—Nausea—Orlistat—type 2 diabetes mellitus	0.000123	0.000692	CcSEcCtD
Ethosuximide—Asthenia—Losartan—type 2 diabetes mellitus	0.000122	0.000684	CcSEcCtD
Ethosuximide—Vomiting—Metformin—type 2 diabetes mellitus	0.000122	0.000683	CcSEcCtD
Ethosuximide—Rash—Metformin—type 2 diabetes mellitus	0.000121	0.000677	CcSEcCtD
Ethosuximide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000121	0.000676	CcSEcCtD
Ethosuximide—Headache—Metformin—type 2 diabetes mellitus	0.00012	0.000673	CcSEcCtD
Ethosuximide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00012	0.00067	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000119	0.000669	CcSEcCtD
Ethosuximide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000116	0.000652	CcSEcCtD
Ethosuximide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000116	0.000649	CcSEcCtD
Ethosuximide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000115	0.000646	CcSEcCtD
Ethosuximide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000115	0.000644	CcSEcCtD
Ethosuximide—Rash—Irbesartan—type 2 diabetes mellitus	0.000114	0.000639	CcSEcCtD
Ethosuximide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000114	0.000638	CcSEcCtD
Ethosuximide—Nausea—Metformin—type 2 diabetes mellitus	0.000114	0.000638	CcSEcCtD
Ethosuximide—Headache—Irbesartan—type 2 diabetes mellitus	0.000113	0.000635	CcSEcCtD
Ethosuximide—Dizziness—Losartan—type 2 diabetes mellitus	0.000113	0.000631	CcSEcCtD
Ethosuximide—Vomiting—Losartan—type 2 diabetes mellitus	0.000108	0.000606	CcSEcCtD
Ethosuximide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000107	0.000602	CcSEcCtD
Ethosuximide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000107	0.000602	CcSEcCtD
Ethosuximide—Rash—Losartan—type 2 diabetes mellitus	0.000107	0.000601	CcSEcCtD
Ethosuximide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000107	0.000601	CcSEcCtD
Ethosuximide—Headache—Losartan—type 2 diabetes mellitus	0.000107	0.000597	CcSEcCtD
Ethosuximide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000105	0.000587	CcSEcCtD
Ethosuximide—Nausea—Losartan—type 2 diabetes mellitus	0.000101	0.000566	CcSEcCtD
Ethosuximide—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000559	CcSEcCtD
Ethosuximide—Dizziness—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000541	CcSEcCtD
Ethosuximide—Vomiting—Ramipril—type 2 diabetes mellitus	9.28e-05	0.00052	CcSEcCtD
Ethosuximide—Rash—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000515	CcSEcCtD
Ethosuximide—Dermatitis—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000515	CcSEcCtD
Ethosuximide—Headache—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000512	CcSEcCtD
Ethosuximide—Nausea—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000486	CcSEcCtD
Ethosuximide—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	1.8e-05	0.000296	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—type 2 diabetes mellitus	1.8e-05	0.000296	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NCOA6—type 2 diabetes mellitus	1.78e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.77e-05	0.000291	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—INS—type 2 diabetes mellitus	1.77e-05	0.00029	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UCP3—type 2 diabetes mellitus	1.75e-05	0.000287	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.75e-05	0.000287	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UCP2—type 2 diabetes mellitus	1.75e-05	0.000287	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.74e-05	0.000286	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.74e-05	0.000286	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.74e-05	0.000286	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A2—type 2 diabetes mellitus	1.7e-05	0.00028	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CPT1A—type 2 diabetes mellitus	1.67e-05	0.000274	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTR—type 2 diabetes mellitus	1.67e-05	0.000274	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PCK1—type 2 diabetes mellitus	1.64e-05	0.000269	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NAMPT—type 2 diabetes mellitus	1.64e-05	0.000269	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.64e-05	0.000269	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GCK—type 2 diabetes mellitus	1.63e-05	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HBA1—type 2 diabetes mellitus	1.63e-05	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LIPC—type 2 diabetes mellitus	1.63e-05	0.000267	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—type 2 diabetes mellitus	1.62e-05	0.000266	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP11A1—type 2 diabetes mellitus	1.62e-05	0.000266	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC9A1—type 2 diabetes mellitus	1.59e-05	0.000261	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CETP—type 2 diabetes mellitus	1.57e-05	0.000258	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3R1—type 2 diabetes mellitus	1.55e-05	0.000254	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NOS3—type 2 diabetes mellitus	1.55e-05	0.000254	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HK1—type 2 diabetes mellitus	1.54e-05	0.000252	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.53e-05	0.000252	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.52e-05	0.000249	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GCKR—type 2 diabetes mellitus	1.48e-05	0.000244	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.48e-05	0.000244	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LPA—type 2 diabetes mellitus	1.48e-05	0.000244	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.48e-05	0.000244	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.48e-05	0.000243	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.48e-05	0.000243	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.48e-05	0.000243	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.48e-05	0.000243	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PSMD6—type 2 diabetes mellitus	1.46e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SNAP25—type 2 diabetes mellitus	1.46e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SREBF1—type 2 diabetes mellitus	1.46e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CTGF—type 2 diabetes mellitus	1.43e-05	0.000235	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDOB—type 2 diabetes mellitus	1.42e-05	0.000234	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-05	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.42e-05	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-05	0.000233	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-05	0.000228	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2E1—type 2 diabetes mellitus	1.34e-05	0.000219	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.33e-05	0.000218	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.33e-05	0.000218	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GLP1R—type 2 diabetes mellitus	1.32e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.32e-05	0.000217	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP3A4—type 2 diabetes mellitus	1.29e-05	0.000211	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GCG—type 2 diabetes mellitus	1.27e-05	0.000208	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—SLC2A4—type 2 diabetes mellitus	1.27e-05	0.000208	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.26e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.26e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.23e-05	0.000203	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.23e-05	0.000202	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTR—type 2 diabetes mellitus	1.21e-05	0.000199	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CPT1A—type 2 diabetes mellitus	1.21e-05	0.000199	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.21e-05	0.000198	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.21e-05	0.000198	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.2e-05	0.000197	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NAMPT—type 2 diabetes mellitus	1.19e-05	0.000195	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.18e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HBA1—type 2 diabetes mellitus	1.18e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LIPC—type 2 diabetes mellitus	1.18e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GCK—type 2 diabetes mellitus	1.18e-05	0.000194	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.18e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.18e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.18e-05	0.000193	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.17e-05	0.000192	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.17e-05	0.000192	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.15e-05	0.000189	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.15e-05	0.000189	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CETP—type 2 diabetes mellitus	1.14e-05	0.000187	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.13e-05	0.000186	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.11e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.11e-05	0.000182	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-05	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-05	0.000179	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	1.09e-05	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	1.07e-05	0.000176	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.07e-05	0.000175	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SNAP25—type 2 diabetes mellitus	1.06e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PSMD6—type 2 diabetes mellitus	1.06e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SREBF1—type 2 diabetes mellitus	1.06e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.06e-05	0.000173	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.06e-05	0.000173	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.06e-05	0.000173	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	1.04e-05	0.000171	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CTGF—type 2 diabetes mellitus	1.04e-05	0.00017	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.04e-05	0.00017	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.03e-05	0.00017	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMGCR—type 2 diabetes mellitus	1.03e-05	0.000169	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.03e-05	0.000169	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-05	0.000166	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.01e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	9.93e-06	0.000163	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.77e-06	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.77e-06	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	9.72e-06	0.00016	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	9.69e-06	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	9.65e-06	0.000158	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.56e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.56e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	9.54e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	9.54e-06	0.000157	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.52e-06	0.000156	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	9.44e-06	0.000155	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.33e-06	0.000153	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	9.32e-06	0.000153	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	9.31e-06	0.000153	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	9.17e-06	0.000151	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.17e-06	0.000151	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	9.15e-06	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	9.15e-06	0.00015	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.08e-06	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.08e-06	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.08e-06	0.000149	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	8.94e-06	0.000147	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	8.77e-06	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.71e-06	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.71e-06	0.000143	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	8.5e-06	0.000139	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.38e-06	0.000138	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.38e-06	0.000138	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	8.35e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	8.32e-06	0.000137	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.24e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	8.23e-06	0.000135	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.1e-06	0.000133	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.1e-06	0.000133	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.1e-06	0.000133	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.9e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	7.9e-06	0.00013	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.89e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	7.89e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	7.87e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	7.85e-06	0.000129	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	7.76e-06	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	7.74e-06	0.000127	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.61e-06	0.000125	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	7.53e-06	0.000124	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	7.52e-06	0.000123	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	7.33e-06	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	7.31e-06	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	7.25e-06	0.000119	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	7.19e-06	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	7.18e-06	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.13e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—type 2 diabetes mellitus	7.12e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	7.11e-06	0.000117	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	7.04e-06	0.000116	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	7.03e-06	0.000115	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	7.02e-06	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7e-06	0.000115	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.88e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.88e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.88e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.88e-06	0.000113	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	6.84e-06	0.000112	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	6.82e-06	0.000112	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.75e-06	0.000111	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	6.74e-06	0.000111	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	6.52e-06	0.000107	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	6.48e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	6.46e-06	0.000106	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	6.35e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.34e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	6.24e-06	0.000102	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	6.24e-06	0.000102	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	6.15e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	6.14e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.14e-06	0.000101	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	6.05e-06	9.94e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.04e-06	9.91e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	6.03e-06	9.9e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.02e-06	9.88e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	5.96e-06	9.79e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	5.95e-06	9.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.73e-06	9.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	5.7e-06	9.37e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.61e-06	9.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.61e-06	9.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.5e-06	9.04e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.47e-06	8.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.47e-06	8.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.47e-06	8.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.44e-06	8.92e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.34e-06	8.76e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.28e-06	8.66e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	5.25e-06	8.62e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.24e-06	8.61e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	5.15e-06	8.46e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.14e-06	8.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.91e-06	8.05e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.91e-06	8.05e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.91e-06	8.05e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.82e-06	7.91e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.77e-06	7.83e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	4.72e-06	7.75e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	4.71e-06	7.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.67e-06	7.67e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	4.52e-06	7.42e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.52e-06	7.42e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.51e-06	7.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.51e-06	7.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.49e-06	7.37e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.44e-06	7.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.44e-06	7.28e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.25e-06	6.98e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.25e-06	6.98e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	4.13e-06	6.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.12e-06	6.77e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.67e-06	6.02e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.67e-06	6.02e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.65e-06	5.99e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.6e-06	5.91e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.5e-06	5.74e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.4e-06	5.58e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.34e-06	5.48e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.27e-06	5.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.26e-06	5.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.17e-06	5.21e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.13e-06	5.14e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.01e-06	4.93e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.95e-06	4.84e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.87e-06	4.71e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.86e-06	4.69e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.81e-06	4.61e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.8e-06	4.59e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.77e-06	4.54e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.44e-06	4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.39e-06	3.92e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.19e-06	3.6e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.1e-06	3.44e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.1e-06	3.44e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	3.41e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.07e-06	3.4e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.92e-06	3.15e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.63e-07	1.58e-05	CbGpPWpGaD
